ClinicalTrials.Veeva

Menu

Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo Controlled Clinical Trial

I

Isfahan University of Medical Sciences

Status

Completed

Conditions

Knee Arthroplasty, Total

Treatments

Drug: Normal saline
Drug: Tranexamic Acid

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Total Knee Arthroplasty (TKA) is a common orthopedic surgery usually leads to Bleeding. The null hypothesis of this study was that TA has no effect on post surgical bleeding in patients undergoes TKA.

Enrollment

90 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals with osteoarthritis who indicated for primary TKA.

Exclusion criteria

  • Previous history of ceberovascular diseases
  • Previous history of myocardial infarction
  • Candidates for bilateral TKA

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups, including a placebo group

Tranexamic acid
Experimental group
Treatment:
Drug: Tranexamic Acid
Normal Saline
Placebo Comparator group
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems